Composition for preventing or treating hyperlipidemia
AssigneeHawon Pharm. Corporation
InventorsDae-Ho KOOH, Sung-Kew KIM, Young-Chan BAIK, Young-Bong SHIN, Myoung Seok KIM
Life of this patent
Estimating the term…
Loading patent…
AssigneeHawon Pharm. Corporation
InventorsDae-Ho KOOH, Sung-Kew KIM, Young-Chan BAIK, Young-Bong SHIN, Myoung Seok KIM
Estimating the term…
A pharmaceutical composition for preventing or treating hyperlipidemia includes a Salvia miltiorrhiza extract, a Crataegus pinnatifida extract, a Polygonum multiflorum extract, and a Ligusticum chuanxiong extract, thereby reducing the amounts of serum cholesterol and LDL-cholesterol and increasing the amount of HDL-cholesterol; significantly reduces the amount of serum triglyceride compared with existing statin-based drugs, thereby exhibiting prophylactic and therapeutic effects of hyperlipidemia with various symptoms even without the co-administration of other drugs; and reduces the amounts of hepatic cholesterol and triglyceride, thereby exhibiting an effect of inhibiting fatty liver.
A pharmaceutical composition for preventing or treating hyperlipidemia, comprising a Salvia miltiorrhiza extract, a Crataegus pinnatifida extract, a Polygonum multiflorum extract, and a Ligusticum chuanxiong extract.
A health functional food for the improvement of hyperlipidemia, comprising a Salvia miltiorrhiza extract, a Crataegus pinnatifida extract, a Polygonum multiflorum extract, and a Ligusticum chuanxiong extract.
Dependencies are inferred from the claim text.